Nu Skin Enterprises Inc (NUS)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $191.31M
Last updated: Nov 17, 2026 at 4:24 PM ET
Nu Skin Enterprises Inc (NUS) Statistics
Nu Skin Enterprises (NUS) has a market cap of $191.31M and an enterprise value of $278.82M. Its trailing P/E of 5.2x is below its 10-year median of 12.4x. Its dividend yield is 6.32%.
Total Valuation
Enterprise value is 45.75% above the market cap, as debt exceeds cash.
| Market Cap | $191.31M |
|---|---|
| Enterprise Value | $278.82M |
| Latest price (Nov 17, 2026) | $3.80 |
Key Dates
The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Nov 27, 2026.
| Next Earnings Date | Feb 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Next Ex-Dividend Date | Nov 27, 2026 |
| Next Payment Date | Dec 9, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.1x and 0.3x. Its year-end P/E ranged from 3.0x to 21.1x from 2016 to 2025.
| P/E Ratio | 5.2x |
|---|---|
| Forward P/E | 4.6x |
| P/S Ratio | 0.1x |
| Forward P/S | 0.1x |
| P/B Ratio | 0.3x |
| P/TBV Ratio | 0.4x |
| P/OCF Ratio | 12.6x |
Enterprise Valuation
Counting debt and cash, the company is valued at 10.9x EBITDA.
| EV / Sales | 0.2x |
|---|---|
| EV / EBITDA | 10.9x |
Price Statistics
The stock is down 59.98% over 52 weeks and trades 18.28% below its 50-day average.
| Beta (1Y) | 0.79 |
|---|---|
| 52-Week Change | -59.98% |
| 1-Month Change | -23.54% |
| 3-Month Change | -19.69% |
| 6-Month Change | -31.81% |
| 5-Year Change | -88.42% |
| 10-Year Change | -92.46% |
| Total Return (1Y) | -57.45% |
| Total Return (3Y CAGR) | -39.11% |
| Total Return (5Y CAGR) | -37.35% |
| Return vs SPY (1Y) | -71.16% |
| Max Drawdown (1Y) | -66.49% |
| Max Drawdown (3Y) | -80.46% |
| Sharpe Ratio (1Y) | -1.97 |
| Correlation with SPY (1Y) | 0.24 |
| 50-Day Average | $4.65 |
| 200-Day Average | $5.92 |
| 52-Week Range | $3.84 to $11.33 |
| RSI (14 Days) | 32.8 |
| Average Volume (20 Days) | 566.26K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.04x current liabilities, and total debt is 0.46x shareholder equity.
| Current Ratio | 2.04x |
|---|---|
| Quick Ratio | 1.22x |
| Debt / Equity | 0.46x |
| Debt / EBITDA | 10.09x |
| Interest Coverage | 15.07x |
Returns and Efficiency
Return on invested capital is -3.18% over the last 12 months, against a 5-year average of 5.38%.
| Return on Equity (ROE) | -42.78% |
|---|---|
| Return on Assets (ROA) | -21.53% |
| Return on Invested Capital (ROIC) | -3.18% |
| Return on Capital Employed (ROCE) | -2.98% |
| ROE (5Y Average) | 5.25% |
| ROA (5Y Average) | 3.07% |
| ROIC (5Y Average) | 5.38% |
| Asset Turnover | 1.05x |
| Inventory Turnover | 2.22x |
| Receivables Turnover | 26.36x |
| Cash Conversion Cycle | 151 days |
Scores
NUS has an Altman Z-Score of 3.67, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.67 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.32B over the last 12 months is down 15.27% from the 12 months before.
| Revenue | $1.32B |
|---|---|
| Revenue Growth (YoY) | -15.27% |
| Gross Profit | $896.94M |
| Operating Income | -$26.96M |
| Pretax Income | -$40.50M |
| Net Income | -$234.21M |
| EBITDA | $25.01M |
| EBIT | -$25.43M |
| Reported EPS (TTM) | $0.73 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 50.23% of the $1.09B in total assets.
| Cash and Equivalents | $164.90M |
|---|---|
| Total Debt | $252.42M |
| Net Debt | $87.51M |
| Net Debt Per Share | $1.80 |
| Working Capital | $244.23M |
| Shareholder Equity | $547.48M |
| Book Value Per Share | $11.25 |
| Tangible Book Value | $506.35M |
| Tangible Book Per Share | $10.40 |
| Total Assets | $1.09B |
| Total Liabilities | $540.60M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $41.46M of capital spending, operating cash flow left -$26.26M of free cash flow.
| Operating Cash Flow | $15.21M |
|---|---|
| Capital Expenditures | $41.46M |
| Free Cash Flow | -$26.26M |
| FCF Per Share | -$0.54 |
| Depreciation and Amortization | $50.45M |
| Dividends Paid | $18.12M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -2.04%, against a 5-year average of 2.36%.
| Gross Margin | 67.84% |
|---|---|
| Operating Margin | -2.04% |
| Pretax Margin | -3.06% |
| Net Margin | -17.72% |
| EBITDA Margin | 1.89% |
| EBIT Margin | -1.92% |
| FCF Margin | -1.99% |
| Gross Margin (5Y Average) | 70.64% |
| Operating Margin (5Y Average) | 2.36% |
| Net Margin (5Y Average) | 2.59% |
Growth
Revenue fell 12.61% a year over 3 years, and EPS grew 3.41% a year.
| Revenue Growth (3Y CAGR) | -12.61% |
|---|---|
| Revenue Growth (5Y CAGR) | -10.47% |
| EPS Growth (3Y CAGR) | +3.41% |
| EPS Growth (5Y CAGR) | -2.62% |
| FCF Growth (3Y CAGR) | -2.08% |
| FCF Growth (5Y CAGR) | -31.95% |
| Operating Income Growth (3Y CAGR) | -15.97% |
| Book Value Per Share Growth (2Y CAGR) | -1.45% |
| Tangible Book Per Share Growth (2Y CAGR) | +15.05% |
Dividends and Yields
NUS pays out 7.29% of earnings as dividends.
| Dividend Per Share (Annual) | $0.24 |
|---|---|
| Dividend Yield | 6.32% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | -46.19% |
| Dividend Growth (5Y CAGR) | -30.69% |
| Payout Ratio | 7.29% |
| Earnings Yield | 19.23% |
| FCF Yield | -14.20% |
| Buyback Yield | 8.13% |
| Shareholder Yield | 17.92% |
Peer Position
Against 8 similar companies, NUS has the lowest P/E.
P/E RatioPeer median 17.6x
P/S RatioPeer median 0.9x
ROICPeer median 2.15%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -0.78%
Dividend YieldPeer median 0.00%
| P/E Ratio | 5.2x vs 17.6x median |
|---|---|
| P/S Ratio | 0.1x vs 0.9x median |
| ROIC | -3.18% vs 2.15% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -15.27% vs -0.78% median |
| Dividend Yield | 6.32% vs 0.00% median |
Analyst Forecast
Consensus estimates put revenue growth at -2.76% and EPS growth at -40.54% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -2.76% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -40.54% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NUS
What is NUS's market cap?
Nu Skin Enterprises has a market cap of $191.31M. Its enterprise value, which adds debt and subtracts cash, is $278.82M.
What is NUS's P/E ratio?
Nu Skin Enterprises has a trailing P/E ratio of 5.2x and a forward P/E of 4.6x.
How many shares of NUS are outstanding?
Nu Skin Enterprises has 48.68M shares outstanding. The count is down 1.46% from a year earlier.
Does NUS pay a dividend?
Yes. Nu Skin Enterprises pays $0.24 a share a year, a dividend yield of 6.32%.
How much debt does NUS have?
Nu Skin Enterprises has $252.42M of total debt and $164.90M of cash and equivalents, a net debt position of $87.51M.
NUS pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors